Journal of Virological Methods
ISSN 0166-0934 · Elsevier BV · Netherlands · active 1894–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Journal of Virological Methods a predatory journal?
Our screening does not flag Journal of Virological Methods. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Journal of Virological Methods indexed in Scopus or Web of Science?
Per our venue index, Journal of Virological Methods appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Journal of Virological Methods's impact?
Papers in Journal of Virological Methods are cited about 1.6 times each within two years of publication, and Scimago places it in Q3, with an h-index of 143. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Journal of Virological Methods open access?
We hold no reliable open-access classification for Journal of Virological Methods. Check the journal's own site for its access model and any article processing charge.
Similar venues
- MMWR Morbidity and Mortality Weekly ReportQ1 · Centers for Disease Control and Prevention
- Clinical Microbiology ReviewsQ1 · American Society for Microbiology
- The Lancet Infectious DiseasesQ1 · Elsevier BV
- Biotechnology AdvancesQ1 · Elsevier BV
- Current Opinion in Chemical EngineeringQ1 · Elsevier BV
- EurosurveillanceQ1 · European Centre for Disease Prevention and Control